Halyard Health, Inc. (NYSE:HYH) Files An 8-K Results of Operations and Financial ConditionItem 2.02Results of Operations and Financial Condition.
Halyard Health, Inc. (the “Company”) announced its results of operations for the three and six months ended June 30, 2017 in a press release dated August 2, 2017, that is attached and incorporated herein by reference as Exhibit 99.1.
The information, including exhibits attached hereto in Item 2.02 of this Current Report, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any registration statement or other document to the Securities Act of 1933, as amended, except as otherwise expressly stated in such filing.
|
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On July 27, 2017, The Board of Directors of the Company (“Board”) accepted the resignation of Robert E. Abernathy as the Chairman of the Board, effective as of September 1, 2017. In connection with Mr. Abernathy’s resignation, the Board elected Ron Dollens as Chairman of the Board, effective as of September 1, 2017.
The Board also approved that, effective as of September 1, 2017, Mr. Dollens, in his role as Chairman of the Board, shall receive additional cash compensation of $115,000, paid in four quarterly installments at the beginning of each quarter, such payments to be in lieu of the additional payments he previously received as Lead Director of the Corporation.
On July 31, 2017, the Company entered into a Retention Incentive Agreement with Christopher M. Lowery, the Company’s Chief Operating Officer. Under the terms of that agreement, Mr. Lowery will be entitled to a cash retention incentive payment of $250,000 if he remains employed by the Company through a CEO transition period that is expected to end on or before December 15, 2017.
Item 9.01Financial Statements and Exhibits.
Exhibit No. 99.1. Press release issued by Halyard Health, Inc. on August 2, 2017.
Halyard Health, Inc. ExhibitEX-99.1 2 hyh2q2017form8kex991.htm EXHIBIT 99.1 Exhibit Investor Contact: Dave Crawford Halyard Health,…To view the full exhibit click here
About Halyard Health, Inc. (NYSE:HYH)
Halyard Health, Inc. seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. The Medical Devices segment provides a portfolio of product offerings focused on pain management and respiratory and digestive health. The S&IP segment’s product portfolio includes sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves. The S&IP segment is also a provider of education to prevent healthcare-associated infections. The Medical Devices segment provides a portfolio of product offerings focused on pain management and respiratory and digestive health. Its products include QUICK CHECK, SMART-FOLD, POWERGUARD, MICROCOOL and FLUIDSHIELD.
